MK 2866 Capsules

$20.00

Chemical Information and Compositions of MK 2866 Capsules

For researchers, biochemists, and wholesale distributors, the molecular structure of mk 2866 capsules is a triumph of modern medicinal chemistry. Understanding its composition is vital for analytical testing, formulation, and predicting its biological behavior.

Official Chemical Nomenclature

  • Chemical Name: 2-[4-[(2E)-3-(4-cyanophenoxy)-2-fluoroprop-2-en-1-yl]phenyl]-5-methyl-1,3-oxazole-4-carbonitrile
  • Chemical Formula: C19H14F3N3O3
  • Molecular Weight: 389.20 g/mol
  • CAS Number: 841205-47-8

Structural Composition Breakdown

mk 2866 capsules contain Ostarine as a free base. Its structural architecture is precisely tailored to exploit the shape of the androgen receptor (AR) ligand-binding domain (LBD):

  1. The Trifluoromethylphenyl Moiety: The inclusion of a trifluoromethyl (-CF3) group on the distal phenyl ring is a classic optimization. The high electronegativity and lipophilicity of the fluorine atoms increase the molecule’s metabolic stability and membrane permeability, preventing rapid hepatic destruction and ensuring high oral bioavailability.
  2. The Cyanophenyl Group: A nitrile (cyano) group attached to the phenyl ring is critical for hydrogen bonding with specific amino acid residues (like Asn705 and Gln711) in the AR, anchoring the molecule securely and driving its high binding affinity.
  3. The Fluoropropenyl Bridge: The 2-fluoroprop-2-en-1-yl linker connects the two aromatic systems. The fluorine atom on this bridge provides conformational rigidity and protects the molecule from oxidative metabolism at this specific site.
  4. The Oxazole Ring: The 5-methyl-1,3-oxazole ring is the defining structural signature of mk 2866 capsules. This bulky, heterocyclic group mimics the C/D ring system of natural steroids. It physically blocks co-activator proteins from binding to the AR in certain tissues (like the prostate), which is the fundamental mechanism of its tissue selectivity.

Physical and Chemical Properties

  • State at Room Temperature: Solid (Crystalline Powder)
  • Color: White to off-white
  • Solubility: Practically insoluble in water; freely soluble in DMSO, PEG 400, ethanol, and methanol. Its poor aqueous solubility necessitates specific excipient matrices for oral capsule formulation.
  • Melting Point: Approximately 82°C to 86°C.

Pharmacokinetics

  • Route of Administration: Oral
  • Absorption: Rapidly and well absorbed from the gastrointestinal tract. Food does not significantly alter bioavailability.
  • Half-Life: The terminal elimination half-life of mk 2866 capsules in humans is approximately 24 hours. This convenient once-daily dosing schedule maintains stable blood plasma levels over a 24-hour period, avoiding the peaks and troughs associated with multiple daily doses.
  • Metabolism: Primarily metabolized in the liver via CYP3A4 and CYP2C19, but it lacks the 17-alpha-alkylation of oral steroids, sparing it from severe hepatotoxic first-pass effects.
  • Excretion: Excreted primarily via the feces through biliary elimination, with a minor renal fraction.

Formulation Details: The Capsule

When you source wholesale mk 2866 capsules, you are dealing with a micro-dose formulation. Standard research doses range from 10mg to 25mg daily.

A 10mg dose equals 0.010 grams. Standard excipients used in the encapsulation process include:

  • Microcrystalline Cellulose (MCC): Filler to provide bulk for precise encapsulation.
  • Magnesium Stearate: Lubricant to ensure smooth powder flow into capsule shells.
  • Hypromellose (HPMC): Often used for vegetarian capsule shells.

For B2B buyers, ensuring the uniform blending of such a microscopic amount of API within the excipient matrix via geometric dilution is critical. Because mk 2866 capsules meaningfully impact the HPTA at higher doses, “hot spots” (capsules containing 50mg+) in a poorly blended batch can cause immediate, severe HPTA shutdown and estrogen crashes.

SKU: N/A Category: